Purchases and Sales Made in Q1 2023 in Karyopharm Therapeutics Inc. (KPTI)
This table provides information about the institutional ownership of Karyopharm Therapeutics Inc. (KPTI) during Q1 2023. The information is specifically focused on institutions that hold shares of Karyopharm Therapeutics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2023
Q1 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-338K- 96.08% |
$959K - $1.32M
|
13.8K
$9.36K
|
|
|
May 12, 2023
Q1 2023
|
Ubs Group Ag
|
SELL
|
- |
-361K- 68.96% |
$1.02M - $1.41M
|
162K
$110K
|
|
|
May 15, 2023
Q1 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-563K- 43.64% |
$1.6M - $2.21M
|
727K
$494K
|
|
|
May 15, 2023
Q1 2023
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
SELL
|
- |
-1.17M- 52.21% |
$3.34M - $4.6M
|
1.08M
$731K
|
|
|
May 11, 2023
Q1 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-1.35M- 91.16% |
$3.84M - $5.3M
|
131K
$89.1K
|
|
|
May 15, 2023
Q1 2023
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-1.99MClosed |
$5.66M - $7.81M
|
0
$0
|
|
|
May 12, 2023
Q1 2023
|
Rubric Capital Management LP
New York, NY |
SELL
|
- |
-3.85M- 46.46% |
$10.9M - $15.1M
|
4.44M
$3.02M
|